Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2008
11/06/2008US20080275022 Substituted Quinazolones as Anti-Cancer Agents
11/06/2008US20080275021 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
11/06/2008US20080275004 N-Substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
11/06/2008US20080274907 Fluorogenic ph sensitive dyes and their method of use
11/06/2008US20080274891 Pyridine-3-ketone compound; plant growth controllers
11/06/2008US20080274107 Tyrosine kinase inhibitors
11/06/2008CA2685567A1 Pyridonecarboxamides, crop protection agents containing the same, method for production and use thereof
11/06/2008CA2685106A1 6-phenylpyrimidinones as pim modulators
11/06/2008CA2683866A1 Bridged six-membered ring compounds
11/05/2008EP1988177A1 Detection of immobilised nucleic acid
11/05/2008EP1988080A1 Insecticidal substituted 2-aminoindanes
11/05/2008EP1988077A1 Nirogenous heterocyclic derivatives substituted with cyclic groups
11/05/2008EP1988075A1 Pyrrole derivative or salt thereof
11/05/2008EP1987831A1 Compounds effecting glucokinase
11/05/2008EP1987717A1 Pyridon carboxamides, agents containing these but not impacting useful plants and method for their manufacture and application
11/05/2008EP1987026A1 Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders
11/05/2008EP1987025A1 Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents
11/05/2008EP1987024A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
11/05/2008EP1987020A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
11/05/2008EP1987019A1 Benzoyl-piperidine derivatives as 5ht2/d3 modulators
11/05/2008EP1987000A2 Diaryl piperidines as cb1 modulators
11/05/2008EP1986498A2 Insecticidal substituted amino heterocyclic and heteroaryl derivatives
11/05/2008EP1858901B1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds
11/05/2008EP1824844B1 Pyrazine dicarboxamides and the use thereof
11/05/2008EP1732921B1 Thioamide derivatives as progesterone receptor modulators
11/05/2008EP1709028B1 Fused heteroaryl derivatives and their use as p38 kinase inhibitors
11/05/2008EP1638969B1 Cgrp receptor antagonists
11/05/2008EP1487828B1 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
11/05/2008EP1296973B1 Guanidine derivatives of quinazoline for use in the treatment of autoimmune diseases
11/05/2008EP1053227B1 Ppar-gamma modulators
11/05/2008CN101300252A Novel cycloalkane carboxamides as factor Xa inhibitors
11/05/2008CN101300250A Heterocycles substituted pyridine derivatives and antifungal agent containing thereof
11/05/2008CN101300249A Aminoquinoline and aminoquinazoline kinase modulators
11/05/2008CN101300235A Diaminopyrimidines as P2X3 and P2X2/3 modulators
11/05/2008CN101298433A 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
11/05/2008CN100430386C Phenylalanine derivatives as depeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/04/2008US7446211 Coupling process for generating reactive boron-containing derivatives of N-substituted pyrrole-2-carbonitriles to produce biaryls
11/04/2008US7446199 Compositions useful as inhibitors of protein kinases
11/04/2008US7446196 Leptomycin compounds
11/04/2008US7446195 High affinity thiophene-based and furan-based kinase ligands
11/04/2008US7446127 reduction of glucose, insulin, free fatty acids; treatment, control and prevention of diabetes, obesity, atherosclerosis, vascular inflammation and their related diseases; e.g. 7-[2-(5-Methyl-2-phenyl-4-oxazolyl)ethoxy]chromane-3-carboxylic Acid
11/04/2008US7446114 minimal side effects, improved selectivity, potency, pharmacokinetics, and/or duration of action; 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[3-(4-methanesulfonylpiperazine-1-sulfonyl)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide; reduced motility of the gastrointestinal tract
11/04/2008US7446113 the prodrug forms of compounds have good absorption, pharmacokinetics, distribution and transport to the brain; 4-[8-Trifluoromethyl-6-(4-trifluoromethyl-phenyl)-imidazo[1,2-a]pyridin-3-ylethynyl]-benzenesulfonamide; nervous system disorders like psychosis, schizophrenia, Alzheimer's disease, depression
11/04/2008US7446110 Benzimidazolyl- or N-hetero analog derivatives of 4-aza-5 alpha -androstan-3-ones, e.g., beta -(1H-imidazo[4,5-c]pyridin-2-yl)-4-methyl-4-aza-5 alpha -androst-1-en-3-one; benign prostate hyperplasia, depression, sexual dysfuction, sleep apnea; ideal for hormone replacement therapy in hypogonadic men
11/04/2008US7446109 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
11/04/2008CA2443449C Pyrazole derivatives for treating hiv
10/2008
10/30/2008WO2008131000A2 7-substituted indole mcl-1 inhibitors
10/30/2008WO2008130616A2 Diaryl morpholines as cb1 modulators
10/30/2008WO2008130370A1 Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and the use for nonsense suppression
10/30/2008WO2008130368A2 Transcription factor modulating compounds and methods of use thereof
10/30/2008WO2008130322A1 Novel 5-heterocyclyl-chromane derivatives for the treatment of pain
10/30/2008WO2008130214A1 Oxazolidines derived from polyalkyl or polyalkylene n-hydroxyalkyl succinimides, method for preparation and use
10/30/2008WO2008130021A2 Heterocyclic hydrazide compound and pesticidal use of the same
10/30/2008WO2008129380A1 Sulfonyl amide derivatives for the treatment of abnormal cell growth
10/30/2008WO2008129280A1 Pyrazoles useful in the treatment of inflammation
10/30/2008WO2008129054A2 Heterocyclic compounds with affinity to muscarinic receptors
10/30/2008WO2008128985A1 Thiourea derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128951A1 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists
10/30/2008WO2008128919A2 Histamine h3 receptor ligands comprising a cyclobutoxy group
10/30/2008WO2008128832A1 Nitroderivatives of non-peptidic renin inhibitors for the treatment of cardiovascular, renal and chronic liver disease, inflammations and metabolic syndrome
10/30/2008WO2008128436A1 Novel compounds for treatment of psychotic disorders, preparation methods and uses thereof
10/30/2008WO2008128335A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
10/30/2008WO2008064320A3 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
10/30/2008US20080269296 Diaryl ethers as opioid receptor antagonists
10/30/2008US20080269267 Anticancer agents; rheumatic diseases; asthma; chronic obstructive pulmonary disease; neurodegenerative diseases; metabolic disorders
10/30/2008US20080269266 Moderation of insulin-like growth factor receptors; anticancer agents
10/30/2008US20080269254 Antiproliferative agents; anticancer agents; graft versus host disease; rheumatic diseases; vision defects; cardiovascular disorders
10/30/2008US20080269253 Pain therapy; headaches; neurodegenerative diseases; stroke; skin disorders; antiischemic agents; Huntington's disease; antiulcer agents; inflammatory bowel disorders;amyotropic lateral sclerosis
10/30/2008US20080269250 Pyrrolidine and Piperidine Acetylene Derivatives for Use as Mglur5 Antagonists
10/30/2008US20080269245 Histone deacetylase inhibitors; anticancer agents; antiprotozoa agents
10/30/2008US20080269236 Novel 1,2,4 Oxadiazole Compounds and Methods of Use Thereof
10/30/2008US20080269219 Oxazole compound to treat or prevent diabetic neuropathy; 4-(4-chlorophenyl)-5-(3-(2-methoxyphenoxy)propyl-2-methyl-1-imidazolyl)oxazole
10/30/2008US20080269218 using a triazole compound; anticancer agent
10/30/2008US20080269217 Melanocortin-4 receptor binding compounds and methods of use thereof
10/30/2008US20080269216 Gastrointestinal disorders; irritable bowel syndrome
10/30/2008US20080269215 Bisamide Inhibitors of Hedgehog Signaling
10/30/2008US20080269214 Therapy for bacteria infections
10/30/2008US20080269213 8-Hydroxyquinoline compounds and methods thereof
10/30/2008US20080269212 Anticancer agents
10/30/2008US20080269211 Antiserotonine agents; gastrointestinal disorders; irritable bowel syndrome; central nervous system disorders; Alzheimer's disease; cognition activators; analgesics; cardiovascular disorders; antidiabetic agents; sleep disorders
10/30/2008US20080269210 Using 1-(4-((2-(2-aminopyrimidin-5-yl)-4-morpholinothieno(3,2-d)pyrimifin-6-yl)methyl)piperazin-1-yl)-2-(methylsulfony)ethanone; lipid kinase inhibitor; anticancer agents
10/30/2008US20080269207 Anticancer agents; such as 4-acetylamino-1H-pyrazole-3-carboxylic acid (4-fluoro-phenyl)-amide
10/30/2008US20080269200 Antiinflammatory agents; tissue repair; rheumatic disorders; asthma; chronic onstructive pulmonary disease; osteoporosis; psoriasis; Alzheimer's disease; transplant rejection; stroke; antidiabetic agents; glomerulonephritis; anticancer agents
10/30/2008US20080269197 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
10/30/2008US20080269191 Compounds for Nonsense Suppression, Use of These Compounds for the Manufacture of a Medicament for Treating Somatic Mutation-Related Diseases
10/30/2008US20080269059 Pyridinecarboxamides, useful-plant-protecting composition comprising them and processes for their prepartion and their use
10/30/2008US20080267914 Chemical Compounds
10/30/2008US20080267888 Heterocyclic Derivatives
10/30/2008CA2685141A1 New compounds 806
10/30/2008CA2684701A1 Pyrazoles useful in the treatment of inflammation
10/30/2008CA2684385A1 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists
10/30/2008CA2683948A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
10/30/2008CA2682994A1 Heterocyclic compounds with affinity to muscarinic receptors
10/30/2008CA2682539A1 Compounds comprising a cyclobutoxy group
10/30/2008CA2682356A1 7-substituted indole mcl-1 inhibitors
10/30/2008CA2681779A1 Heterocyclic hydrazide compound and pesticidal use of the same
10/30/2008CA2656157A1 Transcription factor modulating compounds and methods of use thereof
10/29/2008EP1984360A2 Compounds and methods for modulating fx-receptors
10/29/2008EP1984359A1 Amorphous and crystalline forms of aprepitant and processes for the preparation thereof
10/29/2008EP1984357A2 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
1 ... 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 ... 647